Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
BIO KEY INTERNATIONAL INC issued 429,027 shares of common stock to Streeterville Capital, LLC.
- Security
- common stock
- Shares
- 429,027 shares
- Purchaser
- Streeterville Capital, LLC
Exact text from the filing
exchange (the “Exchange”) the Partitioned Notes for an aggregate of 429,027 shares (the “Exchange Shares”) of the Company’s Common Stock
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
BIO KEY INTERNATIONAL INC issued 3,091,668 shares of common stock to existing institutional investor.
- Security
- common stock
- Shares
- 3,091,668 shares
- Purchaser
- existing institutional investor
Exact text from the filing
On October 27, 2025, BIO-key International, Inc. (the “Company”) entered into a warrant exercise agreement (the “Warrant Exercise Agreement”) with an existing institutional investor (the “Investor”) to exercise certain outstanding warrants to purchase an aggregate of 3,091,668 shares of the Company’s common stock
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
BIO KEY INTERNATIONAL INC issued 6,183,336 shares of warrant to existing institutional investor for combined purchase price of $0.25 per Existing Warrant.
- Security
- warrant
- Shares
- 6,183,336 shares
- Purchaser
- existing institutional investor
- Consideration
- combined purchase price of $0.25 per Existing Warrant
Exact text from the filing
Warrants, subject to compliance with the beneficial ownership limitations included in the Existing Warrants, and the payment by the Investor of the combined purchase price of $0.25 per Existing Warrant (the “New Warrant Consideration”), the Investor received new unregistered warrants to purchase up to an aggregate of 6,183,336 shares of the Company’s Common
View on SEC.gov